Johnson & Johnson’s single-dose COVID-19 vaccine shows promising signs against Delta variant
Johnson & Johnson’s single-dose COVID-19 vaccine shows promising signs against Delta variant
The data showed that humoral and cellular immune responses generated by the Johnson & Johnson single-shot COVID-19 vaccine lasted through at least eight months, the latest timepoint recorded in the study thus far.